about
Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders. The pipeline include...
Read More
1.10
-0.01
(-0.90%)
93,989
XNAS Volume
XNAS 15 Jul, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Opus Genetics Inc. Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..